Careers

Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare gentic disorders of metabolism.
NASDAQ: AGIO$102.44 Stock is Up 4.41 (4.50%)

UPCOMING EVENTS

Read more
Monday, December 8, 2014 3:30 p.m. ET
Agios Pharmaceuticals ASH Webcast

CONTACTS

Investor Inquiries:
General inquiries: investors@agios.com

Institutional Investors and Financial Analysts:
Lora Pike
617-649-8608
Lora.pike@agios.com

Media Inquiries:
Dan Budwick
Pure Communications
973-271-6085